, the palm oil is increase from the global CPO market price to be much higher than CPO-DIT, cause the volume of exports was increased, consistent with in 2nd quarter of 2022, Indonesia, the world’s
improvements seen in the 2H17 performance vis-à-vis what we saw during the first half of the year 2017. While production was higher by 6%, EBITDA increased by 20%, highlighting the improve- ment seen on the
quarter of Year 2017 and 2018 were in amounts of Baht 145.75 million and Baht 173.83 million, respectively, which increased by 19.3% compared to the total revenue. The revenue from In-patients and Out
of Baht 57.01 million whereas mark to market price increased of Baht 180.56 million in the same period last year. Fee and service income decreased of Baht 16.37 million from mutual fund and private
profit increased by 218.77% to Baht 46.03 million from Baht 14.44 million in the comparable quarter of 2017. The clarification of the Company operating results is as follows: Revenue from Sales In the 1st
reported Total revenues in 2018 of Baht 654.29 million, a 20.95% increase from 2017. Net profit for 2018 increased by 39.82% to Baht 117.21 million from Baht 83.83 million in 2017, with Net profit margin at
reported Total revenues in 2019 of Thai Baht 911.00 million, a 39.23% increase from 2018 of Thai Baht 654.29. Net profit for 2019 increased by 36.76% to Thai Baht 160.30 million from Thai Baht 117.21 million
195 million in 2Q2017 (47 percent decrease), due to a decrease in the performance of the Company’s investments. 2. The Company’s interest income on margin loans increased from Baht 24 million in 2Q2016
, consist of Cost of sales in real estate development with an increase of Baht 61.52 million.Selling expenses increased of Baht 36. 57 million (Most of the tax is specific business from January to November